Sales Enablement
Content engagement tracking and approved material distribution for life sciences sales and MSL teams.
Overview
Papercurve for Sales Enablement is a content management and analytics platform designed for life sciences sales and Medical Science Liaison (MSL) teams. It supports teams in sharing approved marketing and sales materials, tracking content engagement, and gathering insights to inform follow-up strategies.
The platform addresses common challenges in regulated sales environments, including ensuring that field teams only access current, approved content versions and that marketing teams can measure the return on investment of their materials.
Key Benefits
- Measures content engagement metrics such as clicks and downloads to help prove marketing ROI.
- Provides actionable insights about who is viewing and downloading content, supporting more informed follow-up activity.
- Reduces compliance risk by ensuring sales and MSL teams only access the latest approved versions of content.
Share Link
- Allows users to share tailored sales materials with recipients via a share link.
- Recipients can view or download content without requiring a login.
- Content shared via links is always kept up to date with the latest approved version.
Analytics
- A detailed dashboard displays who is accessing and downloading share link content.
- Tracks how long each document was viewed by recipients.
- Enables teams to identify which contacts are engaging with specific content, supporting targeted follow-up strategies.
Approved Central Repository
- Organises approved sales content in a single, centrally accessible location.
- Ensures all stored content reflects the latest version and has been approved by the relevant team.
- Provides sales and MSL teams with easy access to compliant, current materials.
Papercurve is based in Toronto, Canada, and offers integrations, data security features, and a partner program. Additional resources including case studies and a knowledge base are available through the company's website.
